We are fortunate to live in a time when medical technology and pharmaceuticals can save us from injuries and illnesses that would have killed us a half century ago. Medical conditions such as heart disease and diabetes were death sentences in the not-so-distant past. Today, with prescription drugs, and certain…
Xarelto, a blood thinner linked to irreversible hemorrhaging and other serious medical problems, is now under investigation for problems that may have occurred during the FDA’s initial testing of the drug. The FDA is investigating whether a device used during clinical tests may have negatively affected test results by understating…
Up until recently, people at risk of stroke and blood clotting only had one highly-effective treatment option, warfarin. This decades-old anticoagulant (blood thinner), also known by its brand name Coumadin, has been used by millions of patients since it was introduced to the market in 1954. Although effective, warfarin is…
In the wake of almost countless lawsuits against prescription drug manufacturers, physician groups are advocating a ban on direct-to-consumer advertising. This aggressive form of mass marketing encourages patients to request certain prescription drugs, medical devices, and treatments that they may not otherwise seek out. The American Medical Association (AMA) is…
Xarelto, otherwise known as rivaroxaban, is a prescribed blood thinner manufactured by Bayer and marketed by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. Xarelto was approved by the Food and Drug Administration (FDA) in 2011 for treatment of deep vein thrombosis as well as pulmonary embolism. There is a…
Johnson & Johnson (JNJ) and Bayer AG (BAYN) are combatting efforts to consolidate Xarelto injury lawsuits filed by plaintiffs who claim that the blood thinner caused patients to suffer fatal bleeds. Bayer makes the medication, and J & J owns the rights to the drug in the United States. Some…
Plaintiffs are starting to file claims seeking dangerous drug damages for injuries they sustained from using Xarelto, a blood thinner. Bayer and Johnson & Johnson/Janssen Pharmaceuticals, which jointly market the drug, are the defendants. According to the Xarelto injury lawsuits, users are experiencing internal bleeding so severe that they have…